Routinely reviewing a portfolio is core to any Pharmaceutical business and formal review processes should be established to assess strategic and operational objectives for the coming years
Development candidates, (both early and late-stage) are monitored for progress against fixed benchmarks and/or time periods and significant changes to target plans assessed, (including financial implications, resource requirements, risk of delivery assessments and impact on time lines). Typically, formal reviews are required at least annually, although key changes to plans for major projects are routinely tracked and flagged throughout the year and informal assessments are undertaken regularly.
Strategic objectives of such a review are commonly based on a 5yr view and include;
Operational portfolio management objectives are based on a short-term view (current year (CY) and following year (CY+1) and include;
A formal portfolio review process can be long and wieldy - coordination of simple, consistent, efficient processes, with straightforward templates and project valuation tools, can help enormously.